drugset / Trial / NCT02728687

Topical Menthol +/- Mannitol for Painful Diabetic Peripheral Neuropathy

NCT02728687

Phase 1/2 Completed 72 enrolled University of British Columbia
RandomizedCrossoverQuadruple-blindTreatment

Summary

Treatments for painful diabetic peripheral neuropathy (PDPN) are not very effective and have multiple side effects. To find out if a menthol cream alone or with added mannitol treats PDPN effectively, 90 participants with PDPN, after one month of observation, will receive randomly assigned menthol cream or the same cream with mannitol added for 3 months with a crossover for 3 additional months. At time 0, 1,4 and 7 months their BPI pain severity and interference scores, DN4 scores, cream % effectiveness and side effects will be compared.

Timeline

Start
2017-03-15
Primary completion
2020-03-30
Completion
2020-12-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Mannitol Diagnostic / imaging agent Topical
Background Menthol Small molecule Topical